Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal
Rhea-AI Filing Summary
Glucotrack, Inc. (GCTK) reported the results of its 2026 annual stockholder meeting. There were 7,719,121 shares of common stock outstanding on the record date, and 2,786,974 votes (about 36.10%) were represented in person or by proxy, constituting a quorum.
Stockholders elected six directors to serve until the 2027 annual meeting. They also approved, on an advisory basis, the 2025 executive compensation, and ratified CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026.
Stockholders approved amendments to permit one or more reverse stock splits at an aggregate ratio of up to 1-for-30, and approved a warrant inducement involving repricing certain existing warrants, issuing new inducement warrants and issuing common shares upon their exercise, for purposes of complying with Nasdaq Listing Rule 5635(d).
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding on record date: 7,719,121 shares
Votes represented at meeting: 2,786,974 votes
Quorum percentage: 36.10%
+5 more
8 metrics
Shares outstanding on record date
7,719,121 shares
Common stock issued and outstanding on the record date for the 2026 annual meeting
Votes represented at meeting
2,786,974 votes
Votes present in person or by proxy at the 2026 annual meeting
Quorum percentage
36.10%
Portion of eligible votes represented at the 2026 annual meeting, constituting a quorum
Reverse stock split maximum ratio
1-for-30
Maximum aggregate ratio authorized for one or more reverse stock splits of common stock
Say-on-Pay votes for
962,623 votes
Votes cast in favor of advisory approval of 2025 executive compensation
Auditor ratification votes for
2,621,952 votes
Votes cast in favor of ratifying CBIZ CPAs P.C. as auditor for 2026
Reverse stock split votes for
2,099,338 votes
Votes cast in favor of authorizing reverse stock splits up to 1-for-30
Warrant inducement votes for
895,306 votes
Votes cast in favor of the warrant inducement proposal
Key Terms
Reverse Stock Split, Warrant Inducement, Nasdaq Listing Rule 5635(d), broker non-votes, +1 more
5 terms
Reverse Stock Split financial
"to effect one or more reverse stock splits of the Company’s common stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Warrant Inducement financial
"The approval of a proposed warrant inducement, including the repricing"
Warrant inducement is when a company offers new warrants—options to buy shares at a set price—as a sweetener to persuade investors, lenders, or shareholders to approve a deal or provide financing. Investors should care because these extra warrants can dilute existing ownership if exercised, change the company’s future share supply and potential upside, and alter the risk/reward balance much like giving a coupon that could reduce future prices for original buyers.
Nasdaq Listing Rule 5635(d) regulatory
"for purposes of complying with Nasdaq Listing Rule 5635(d)"
Nasdaq Listing Rule 5635(d) is a stock-exchange rule that determines when a company must get shareholder approval before issuing new shares tied to conversions or exercises of existing convertible securities, options or warrants. It matters to investors because it controls potential dilution of their holdings and changes in voting power—think of it like a rule that decides whether a previously agreed‑upon coupon can be redeemed without asking the group again.
broker non-votes financial
"Abstentions and broker non-votes, if applicable, in respect of each such matter"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Say-on-Pay financial
"approval, on an advisory basis, of the 2025 executive compensation"
A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.
FAQ
What did Glucotrack, Inc. (GCTK) stockholders approve at the 2026 annual meeting?
Stockholders elected six directors, approved 2025 executive compensation, ratified CBIZ CPAs P.C. as auditor for 2026, authorized a reverse stock split of up to 1-for-30, and approved a warrant inducement to comply with Nasdaq Listing Rule 5635(d).
Was Glucotrack’s (GCTK) 2025 executive compensation (Say-on-Pay) approved?
Yes. Stockholders approved the 2025 executive compensation for named executive officers on an advisory basis, with 962,623 votes for, 122,785 against, 33,960 abstentions, and 1,667,606 broker non-votes.
Who is Glucotrack’s (GCTK) auditor for the year ending December 31, 2026?
Stockholders ratified CBIZ CPAs P.C. as Glucotrack’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 2,621,952 votes for, 134,874 against, and 30,148 abstentions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
